Bruno Laugel

2.0k total citations
27 papers, 1.5k citations indexed

About

Bruno Laugel is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Bruno Laugel has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Bruno Laugel's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (18 papers) and Immunotherapy and Immune Responses (15 papers). Bruno Laugel is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (18 papers) and Immunotherapy and Immune Responses (15 papers). Bruno Laugel collaborates with scholars based in United Kingdom, United States and Australia. Bruno Laugel's co-authors include Andrew K. Sewell, David A. Price, Linda Wooldridge, Emma Gostick, David K. Cole, Hugo A. van den Berg, Jonathan M. Boulter, Anne Francez‐Charlot, Marie‐Pierre Castanié‐Cornet and Kaymeuang Cam and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Bruno Laugel

27 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Laugel United Kingdom 20 1.1k 498 338 253 120 27 1.5k
Kangla Tsung United States 20 1.1k 1.0× 596 1.2× 716 2.1× 687 2.7× 81 0.7× 47 1.9k
Yik Y. L. Yu United States 17 1.6k 1.5× 516 1.0× 403 1.2× 208 0.8× 90 0.8× 20 2.0k
Manuel E. Engelhorn United States 14 946 0.9× 419 0.8× 376 1.1× 229 0.9× 68 0.6× 19 1.3k
Reinhard Obst Germany 18 1.3k 1.2× 361 0.7× 667 2.0× 190 0.8× 73 0.6× 26 1.8k
Ilaria Carena Switzerland 11 419 0.4× 168 0.3× 250 0.7× 91 0.4× 50 0.4× 11 925
Danièle Arnold Germany 14 1.2k 1.1× 287 0.6× 902 2.7× 200 0.8× 94 0.8× 19 1.8k
Jaana T. Karttunen United States 8 961 0.9× 184 0.4× 457 1.4× 393 1.6× 47 0.4× 9 1.4k
Terri K. Wade United States 15 1.1k 1.0× 134 0.3× 259 0.8× 118 0.5× 315 2.6× 24 1.4k
Daniëlle J. E. B. Krooshoop Netherlands 7 1.2k 1.1× 278 0.6× 412 1.2× 70 0.3× 93 0.8× 8 1.4k
A. Raúl Castaño Spain 16 1.2k 1.1× 156 0.3× 275 0.8× 53 0.2× 71 0.6× 25 1.4k

Countries citing papers authored by Bruno Laugel

Since Specialization
Citations

This map shows the geographic impact of Bruno Laugel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Laugel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Laugel more than expected).

Fields of papers citing papers by Bruno Laugel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Laugel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Laugel. The network helps show where Bruno Laugel may publish in the future.

Co-authorship network of co-authors of Bruno Laugel

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Laugel. A scholar is included among the top collaborators of Bruno Laugel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Laugel. Bruno Laugel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shamin, Chahrazade Kantari‐Mimoun, Samantha Knockaert, et al.. (2024). In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions. Frontiers in Immunology. 15. 1483258–1483258. 2 indexed citations
2.
Melander, Maria C. & Bruno Laugel. (2023). Abstract LB220: S095029: a novel clinical-stage Fc-silenced NKG2A-blocking antibody with best-in-class potential. Cancer Research. 83(8_Supplement). LB220–LB220. 2 indexed citations
3.
Cole, David K., Hugo A. van den Berg, Angharad Lloyd, et al.. (2016). Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase. Journal of Biological Chemistry. 292(3). 802–813. 19 indexed citations
4.
Meermeier, Erin W., Bruno Laugel, Andrew K. Sewell, et al.. (2016). Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Nature Communications. 7(1). 12506–12506. 94 indexed citations
5.
Laugel, Bruno. (2014). Bench, Bedside, Toolbox: T-Cells Deliver on Every Level. Frontiers in Immunology. 5. 31–31. 1 indexed citations
6.
Berg, Hugo A. van den, Kristin Ladell, Kelly L. Miners, et al.. (2013). Cellular-Level Versus Receptor-Level Response Threshold Hierarchies in T-Cell Activation. Frontiers in Immunology. 4. 250–250. 19 indexed citations
7.
Lloyd, Angharad, Owen N. Vickery, & Bruno Laugel. (2013). Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies. Frontiers in Immunology. 4. 221–221. 33 indexed citations
8.
Laugel, Bruno, Frédéric Borlat, Laurent Galibert, et al.. (2011). Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity. Journal of Neuroimmunology. 240-241. 52–57. 26 indexed citations
9.
Wooldridge, Linda, Mathew Clement, Anna Lissina, et al.. (2010). MHC Class I Molecules with Superenhanced CD8 Binding Properties Bypass the Requirement for Cognate TCR Recognition and Nonspecifically Activate CTLs. The Journal of Immunology. 184(7). 3357–3366. 29 indexed citations
10.
Varela‐Rohena, Angel, Peter Molloy, Steven M. Dunn, et al.. (2008). Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14(12). 1390–1395. 197 indexed citations
11.
Laugel, Bruno, et al.. (2007). CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. European Journal of Immunology. 37(4). 905–913. 22 indexed citations
12.
Gostick, Emma, David K. Cole, Sarah Hutchinson, et al.. (2007). Functional and biophysical characterization of an HLA‐A*6801‐restricted HIV‐specific T cell receptor. European Journal of Immunology. 37(2). 479–486. 20 indexed citations
13.
Wooldridge, Linda, Anna Lissina, Emma Gostick, et al.. (2007). Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. European Journal of Immunology. 37(5). 1323–1333. 55 indexed citations
14.
Laugel, Bruno, Hugo A. van den Berg, Emma Gostick, et al.. (2007). Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties. Journal of Biological Chemistry. 282(33). 23799–23810. 182 indexed citations
15.
Berg, Hugo A. van den, Linda Wooldridge, Bruno Laugel, & Andrew K. Sewell. (2007). Coreceptor CD8-driven modulation of T cell antigen receptor specificity. Journal of Theoretical Biology. 249(2). 395–408. 30 indexed citations
16.
Wooldridge, Linda, Thomas J. Scriba, Bruno Laugel, et al.. (2006). Anti‐coreceptor antibodies profoundly affect staining with peptide‐MHC class I and class II tetramers. European Journal of Immunology. 36(7). 1847–1855. 23 indexed citations
17.
Wooldridge, Linda, Hugo A. van den Berg, Meir Glick, et al.. (2005). Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell Surface. Journal of Biological Chemistry. 280(30). 27491–27501. 135 indexed citations
18.
Laugel, Bruno, Jonathan M. Boulter, Nikolai M. Lissin, et al.. (2004). Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition. Journal of Biological Chemistry. 280(3). 1882–1892. 64 indexed citations
19.
Francez‐Charlot, Anne, Bruno Laugel, Nelly Dubarry, et al.. (2003). RcsCDB His‐Asp phosphorelay system negatively regulates the flhDC operon in Escherichia coli. Molecular Microbiology. 49(3). 823–832. 235 indexed citations
20.
Glick, Meir, David A. Price, Annelise Vuidepot, et al.. (2002). Novel CD8+ T Cell Antagonists Based on β2-Microglobulin. Journal of Biological Chemistry. 277(23). 20840–20846. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kangla Tsung Breakdown of academic impact, for papers by Yik Y. L. Yu Breakdown of academic impact, for papers by Manuel E. Engelhorn Breakdown of academic impact, for papers by Reinhard Obst Breakdown of academic impact, for papers by Ilaria Carena Breakdown of academic impact, for papers by Danièle Arnold Breakdown of academic impact, for papers by Jaana T. Karttunen Breakdown of academic impact, for papers by Terri K. Wade Breakdown of academic impact, for papers by Daniëlle J. E. B. Krooshoop Breakdown of academic impact, for papers by A. Raúl Castaño
Rankless by CCL
2026